Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroblastoma 5 Triple Negative Breast Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Transplant-Related Hematologic Malignancy 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Hodgkin Disease 1 Ganglioneuroblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1 Adenocarcinoma 1

Interventions

Oxaliplatin 42 Fluorouracil 27 Capecitabine 24 pembrolizumab 21 S 1 (combination) 19 Paclitaxel 19 Leucovorin 16 Nivolumab 13 Docetaxel 13 sintilimab 12 Drug Therapy 12 Trastuzumab 11 tislelizumab 10 Cisplatin 10 Irinotecan 9 Bevacizumab 8 trastuzumab deruxtecan 7 spartalizumab 7 XELOX 7 Surgical Procedures, Operative 7 Radiotherapy 7 Hyperthermic Intraperitoneal Chemotherapy 7 Biopsy 7 fludarabine 6 disitamab vedotin 6 Cyclophosphamide 6 lenvatinib 5 apatinib 5 Specimen Handling 5 Ramucirumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Stomach Neoplasms × sargramostim × Clear all

NCT05771584 2024-07-10

Conerstone3

Aston Sci. Inc.

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡